IBYME 02675
INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Soluble tumor necrosis factor alpha blockade inhibits cell migration, tumor growth, and induces innate immune response in lapatinib-resistant HER2+ breast cancer.
Autor/es:
MAURO F; MERCOGLIANO MF; ROLDÁN DEAMICIS AGUSTINA; ELIZALDE PV; BRUNI S; DE MARTINO M; SCHILLACI R
Reunión:
Congreso; Frontiers in Cancer Immunotherapy 2020; 2020
Resumen:
Bruni S, Mauro F, RoldánDeamicis A, De Martino M,. Mercogliano MF, Elizalde PV, Schillaci R. Soluble tumor necrosis factoralpha blockade inhibits cell migration, tumor growth, and induces innate immuneresponse in lapatinib-resistant HER2+ breast cancer. Frontiers in CancerImmunotherapy 2020. New York Accademy of Science, New York, virtual oralpresentation. 11-12 mayo 2020.
